Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid CancerSamuel A. Wells, Martin Schlumberger, David G. Pfister et al.|Journal of Clinical Oncology|2010Cited by 517
Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid CancerBruce G. Robinson, Robert I. Haddad, Luis Paz‐Ares et al.|The Journal of Clinical Endocrinology & Metabolism|2010Cited by 255